Aurobindo Pharma

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue5,7976,5006,6086,9677,406
Expenses5,2725,8195,8726,0826,332
EBITDA847.981,0471,1371,2681,560
EBIT548.65725.07785.66868.581,144
Profit Before Tax523.36680.11730.06812.031,076
Net Profit410.37491.01505.91569.71751.94
Financial Ratios
Operating Profit Margin14.92%16.38%17.73%17.60%21.83%
Net Profit Margin7.22%7.69%7.94%9.00%10.59%
Earning Per Share (Diluted)6.998.388.649.7412.83
Dividends Per Share0.003.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ